Clinical Trial Update: Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients [Phase 2]

View source ↗

Summary

Phase 2 trial results assess the efficacy and tolerability of memantine in patients with frontotemporal dementia. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Frontotemporal Dementia

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Nantes University Hospital | Conditions: Dementia | Phase 2 | Status: COMPLETED